Antipsychotic drug side effect issues in bipolar manic patients
- PMID: 10811244
Antipsychotic drug side effect issues in bipolar manic patients
Abstract
While the efficacy of antipsychotics as a maintenance treatment for bipolar patients has not been systematically studied, these drugs are commonly used in the long-term treatment of bipolar patients, and it is not unusual for a bipolar patient to be taking 3 to 4 medications, including antipsychotics. Conventional antipsychotics may be comparable to lithium for acute mania, but have limitations when used in the long-term treatment of bipolar disorder. Their adverse effects, which include extrapyramidal side effects, tardive dyskinesia, weight gain, sedation, and sexual dysfunction, often lead to non-compliance; their use may have a negative impact on the overall course of illness; and they may not be as effective as lithium in treating the core manic symptoms over the long term. Atypical antipsychotics may prove useful for bipolar patients who require antipsychotic treatment because of their favorable side effect profile, thymoleptic properties, and positive effect on overall functioning.
Similar articles
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
-
Use of atypical antipsychotics in mood disorders.Curr Opin Investig Drugs. 2001 Jul;2(7):940-5. Curr Opin Investig Drugs. 2001. PMID: 11757795 Review.
-
Two new atypical antipsychotics: advantages and disadvantages.S D J Med. 1998 Aug;51(8):285-6. S D J Med. 1998. PMID: 9724957 No abstract available.
-
Atypical antipsychotics: newer options for mania and maintenance therapy.Bipolar Disord. 2005;7 Suppl 4:21-33. doi: 10.1111/j.1399-5618.2005.00212.x. Bipolar Disord. 2005. PMID: 15948764 Review.
-
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.J Clin Psychiatry. 2005;66 Suppl 3:5-11. J Clin Psychiatry. 2005. PMID: 15762829 Review.
Cited by
-
Olanzapine: a review of its use in the treatment of bipolar I disorder.CNS Drugs. 2001;15(11):871-904. doi: 10.2165/00023210-200115110-00005. CNS Drugs. 2001. PMID: 11700151 Review.
-
Post-marketing safety concerns with lumateperone: a pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database.Front Pharmacol. 2024 May 9;15:1389814. doi: 10.3389/fphar.2024.1389814. eCollection 2024. Front Pharmacol. 2024. PMID: 38783948 Free PMC article.
-
Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights.CNS Drugs. 2007;21(5):367-87. doi: 10.2165/00023210-200721050-00002. CNS Drugs. 2007. PMID: 17447826 Review.
-
Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series.Glob Adv Health Med. 2015 Mar;4(2):53-60. doi: 10.7453/gahmj.2014.064. Glob Adv Health Med. 2015. PMID: 25984407 Free PMC article.
-
Clinical response of quetiapine in rapid cycling manic bipolar patients and lactate level changes in proton magnetic resonance spectroscopy.Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1182-8. doi: 10.1016/j.pnpbp.2007.04.009. Epub 2007 Apr 24. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17532107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical